Drug intelligence / Profile preview

Tiagin

Development stage
Phase 3
Lead developer
IDI Pharma
Modality
Small Molecules, Nanoparticles → Drug Delivery Systems
Administration
Vaginal
01

Overview

Tiagin is a vaginal topical treatment formulated as softgel capsules containing **TIAB** (a patented complex of microcrystalline titanium dioxide and covalently linked monovalent silver ions), sodium hyaluronate, and *Aloe barbadensis* extract. It is primarily utilized as an adjuvant therapy to prevent postoperative complications following gynecological surgeries, such as total hysterectomy or cervical conization, and to manage vaginal infections including those caused by bacteria, fungi, and viruses (e.g., HPV). The TIAB component functions as a broad-spectrum antimicrobial by releasing silver ions that disrupt microbial membranes and DNA while also preventing the formation of pathogenic biofilms. The addition of sodium hyaluronate and aloe extract facilitates tissue repair and re-epithelialization by maintaining a hydrated environment and stimulating collagen production and modeling.

Brand names
Tiagin
Other names
TIAB vaginal capsules
02

Targets

Neuraminidase

Beyond the preview

Go deeper on Tiagin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tiagin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call